ExoZymes Inc. Amends Corporate Governance Documents
Ticker: EXOZ · Form: 8-K · Filed: Feb 11, 2025 · CIK: 2010788
| Field | Detail |
|---|---|
| Company | Exozymes Inc. (EXOZ) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, bylaws, amendment
Related Tickers: EXOZ
TL;DR
EXOZ filed an 8-K for bylaw changes, details TBD.
AI Summary
ExoZymes Inc. filed an 8-K on February 10, 2025, reporting amendments to its Articles of Incorporation or Bylaws. The filing indicates that the company's common stock trades under the symbol EXOZ on the Nasdaq Capital Market. No specific details regarding the nature or impact of these amendments were provided in the excerpt.
Why It Matters
Changes to a company's articles of incorporation or bylaws can affect shareholder rights, corporate structure, and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is a procedural update regarding corporate governance documents and does not immediately present financial or operational risks.
Key Players & Entities
- ExoZymes Inc. (company) — Registrant
- February 10, 2025 (date) — Date of earliest event reported
- EXOZ (stock_symbol) — Trading Symbol for Common Stock
- Nasdaq Capital Market (exchange) — Exchange where Common Stock is registered
FAQ
What specific amendments were made to ExoZymes Inc.'s Articles of Incorporation or Bylaws?
The provided excerpt does not specify the details of the amendments made to the Articles of Incorporation or Bylaws.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 10, 2025.
What is the trading symbol for ExoZymes Inc.'s common stock?
The trading symbol for ExoZymes Inc.'s common stock is EXOZ.
On which exchange is ExoZymes Inc.'s common stock registered?
ExoZymes Inc.'s common stock is registered on the Nasdaq Capital Market.
Is ExoZymes Inc. an emerging growth company?
Yes, ExoZymes Inc. has indicated it is an emerging growth company.
Filing Stats: 406 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2025-02-11 17:27:46
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex3-1.htm (EX-3.1) — 3KB
- ex3-1_001.jpg (GRAPHIC) — 1123KB
- ex3-1_002.jpg (GRAPHIC) — 2426KB
- ex3-1_003.jpg (GRAPHIC) — 1845KB
- 0001493152-25-005961.txt ( ) — 7638KB
- exoz-20250210.xsd (EX-101.SCH) — 3KB
- exoz-20250210_lab.xml (EX-101.LAB) — 33KB
- exoz-20250210_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 11, 2025 EXOZYMES INC. By /s/ Fouad Nawaz Fouad Nawaz, Vice President, Finance